NFA
TXMD icon

Nationwide Fund Advisors’s TherapeuticsMD TXMD Stock Holding History

Nationwide Fund Advisors’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-1,748
Closed -$462K – 1961
2017
Q3 		$462K Hold
1,748
– – ﹤0.01% 2226
2017
Q2 		$461K Hold
1,748
– – ﹤0.01% 2228
2017
Q1 		$629K Sell
1,748
-117
-6% -$36.2K ﹤0.01% 2034
2016
Q4 		$538K Sell
1,865
-103
-5% -$31.9K ﹤0.01% 2148
2016
Q3 		$670K Sell
1,968
-702
-26% -$256K ﹤0.01% 2019
2016
Q2 		$1.14M Buy
2,670
+807
+43% +$333K ﹤0.01% 1652
2016
Q1 		$608K Buy
1,863
+181
+11% +$61.7K ﹤0.01% 1985
2015
Q4 		$872K Buy
1,682
+35
+2% +$12.9K ﹤0.01% 1794
2015
Q3 		$483K Hold
1,647
– – ﹤0.01% 2140
2015
Q2 		$647K Buy
1,647
+19
+1% +$6.7K ﹤0.01% 2105
2015
Q1 		$492K Sell
1,628
-20
-1% -$4.88K ﹤0.01% 2244
2014
Q4 		$367K Hold
1,648
– – ﹤0.01% 2362
2014
Q3 		$382K Buy
1,648
+104
+7% +$26.2K ﹤0.01% 2359
2014
Q2 		$341K Buy
1,544
+207
+15% +$46.1K ﹤0.01% 2473
2014
Q1 		$422K Buy
1,337
+8
+0.6% +$2.55K ﹤0.01% 2131
2013
Q4 		$346K Buy
1,329
+96
+8% +$21K ﹤0.01% 2415
2013
Q3 		$181K Buy
1,233
+733
+147% +$88.6K ﹤0.01% 2705
2013
Q2 		$76K Buy
+500
New +$68.5K ﹤0.01% 2876

Other funds holding TXMD

Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Nationwide Fund Advisors's TXMD Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of TherapeuticsMD (TXMD) in Q4 2017, closing a stake of 1,748 shares — an estimated $462K sold.

Nationwide Fund Advisors first reported a position in TXMD in Q2 2013 and held it in 18 quarters. The position peaked at $1.14M in Q2 2016. 144 funds tracked by Wall St. Rank hold TXMD as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining TherapeuticsMD position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 1,748 TherapeuticsMD shares in Q4 2017, an estimated $462K.
  • Nationwide Fund Advisors first reported a position in TherapeuticsMD in Q2 2013 and held it in 18 quarters.
  • Nationwide Fund Advisors's TherapeuticsMD position peaked at $1.14M in Q2 2016.
  • 144 funds tracked by Wall St. Rank held TherapeuticsMD as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.